Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.

H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~ G1/2
26/HR43/R1104
PAGE 1 (MCL\KP)

To: Drug Policy
MISSISSIPPI LEGISLATURE REGULAR SESSION 2026

By: Representative Creekmore IV

HOUSE BILL NO. 563

AN ACT TO AMEND SECTION 41-29-111, MISSISSIPPI CODE OF 1972, 1
TO PROVIDE FOR AUTOMATIC STATE SCHEDULING OF PSILOCYBIN AFTER 2
FEDERAL SCHEDULING; TO BRING FORWARD SECTIONS 41-29-113 THROUGH 3
41-29-121, MISSISSIPPI CODE OF 1972, WHICH RELATE TO THE UNIFORM 4
CONTROLLED SUBSTANCES LAW, FOR PURPOSES OF POSSIBLE AMENDMENT; AND 5
FOR RELATED PURPOSES. 6
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 7
SECTION 1. Section 41-29-111, Mississippi Code of 1972, is 8
amended as follows: 9
41-29-111. (1) The Commissioner of Public Safety shall 10
administer this article and shall work in conjunction and 11
cooperation with the State Board of Pharmacy, county and municipal 12
law enforcement agencies, the district and county attorneys, the 13
Office of the Attorney General and the Mississippi Bureau of 14
Narcotics. The State Board of Health shall work with the bureau 15
in an advisory capacity and shall be responsible for recommending 16
to the Legislature the appropriate schedule for all substances to 17
be scheduled or rescheduled in Sections 41-29-113 through 18
41-29-121. In making a recommendation regarding a substance, the 19
State Board of Health shall consider the following: 20
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 2 (MCL\KP)

(a) (i) The actual or relative potential for abuse; 21
(ii) The scientific evidence of its 22
pharmacological effect, if known; 23
(iii) The state of current scientific knowledge 24
regarding the substance; 25
(iv) The history and current pattern of abuse; 26
(v) The scope, duration and significance of abuse; 27
(vi) The risk to the public health; 28
(vii) The potential of the substance to produce 29
psychic or physiological dependence liability; and 30
(viii) Whether the substance is an immediate 31
precursor of a substance already controlled under this article. 32
(b) After considering the factors enumerated in 33
paragraph (a), the State Board of Health shall make findings with 34
respect thereto and issue a recommendation to control the 35
substance if it finds the substance has a potential for abuse. 36
(c) If the State Board of Health designates a substance 37
as an immediate precursor, substances that are precursors of the 38
controlled precursor shall not be recommended for control solely 39
because they are precursors of the controlled precursor. 40
(d) If any substance is designated, rescheduled, or 41
deleted as a controlled substance under federal law and notice 42
thereof is given to the State Board of Health, it shall recommend 43
the control of the substance under this article at the next 44
session of the Legislature. 45
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 3 (MCL\KP)

(e) (i) Authority to control under this article does 46
not extend to distilled spirits, wine, malt beverages, or tobacco 47
as those terms are defined or used in the Local Option Alcoholic 48
Beverage Control Law, being Sections 67-1-1 through 67-1-91, and 49
the Tobacco Tax Law of 1934, being Sections 27-69-1 through 50
27-69-77. It is the intent of the Legislature of the State of 51
Mississippi that the bureau shall concentrate its efforts and 52
resources on the enforcement of the Uniform Controlled Substances 53
Law with respect to illicit narcotic and drug traffic in the 54
state. 55
(ii) The controlled substances listed in the 56
schedules in Sections 41-29-113 through 41-29-121 are included by 57
whatever official, common, usual, chemical or trade name 58
designated. 59
(f) The State Board of Health shall recommend the 60
exclusion of any nonnarcotic substance from a schedule if such 61
substance may, under the Federal Food, Drug and Cosmetic Act and 62
the laws of this state, be lawfully sold over the counter without 63
a prescription. 64
(2) Any drug that is scheduled on the federal schedule for 65
the purpose of preventing or treating COVID-19 is automatically 66
scheduled on the corresponding state schedule in Sections 67
41-29-113 through 41-29-121. This automatic scheduling is 68
effective from the date that the COVID-19-related drug is 69
designated on the federal schedule until the effective date of 70
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 4 (MCL\KP)

legislation amending the corresponding state schedule in the next 71
regular session of the Legislature. 72
(3) Not withstanding any law to the contrary, any 73
pharmaceutical composition of crystalline polymorph psilocybin 74
that is approved by the United States Food and Drug Administration 75
and is then scheduled by the United States Drug Enforcement 76
Administration is automatically scheduled on the corresponding 77
state schedule in Sections 41-29-113 through 41-29-121. This 78
automatic scheduling is effective from the date that the drug is 79
designated on the federal schedule until the effective date of 80
legislation amending the corresponding state schedule in the next 81
regular legislative session of the Legislature. 82
SECTION 2. Section 41-29-113, Mississippi Code of 1972, is 83
brought forward as follows: 84
41-29-113. 85
SCHEDULE I 86
(a) Schedule I consists of the drugs and other substances, 87
by whatever official name, common or usual name, chemical name, or 88
brand name designated, that is listed in this section. 89
(b) Opiates. Unless specifically excepted or unless listed 90
in another schedule, any of the following opiates, including their 91
isomers, esters, ethers, salts and salts of isomers, esters and 92
ethers, whenever the existence of these isomers, esters, ethers 93
and salts is possible within the specific chemical designation: 94
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 5 (MCL\KP)

(1) Acetyl-alpha-methylfentanyl 95
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); 96
(2) Acetylmethadol; 97
(3) Acetyl fentanyl 98
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 99
(4) Acryl fentanyl 100
(N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide), also known as 101
acryloylfentanyl; 102
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) 103
cyclohexylmethyl]benzamide); 104
(6) Allylprodine; 105
(7) Alphacetylmethadol, except levo-alphacetylmethadol 106
(levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); 107
(8) Alphameprodine; 108
(9) Alphamethadol; 109
(10) Alpha′-methyl butyryl fentanyl 110
(2-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 111
(11) Alpha-Methylfentanyl 112
(N-[1-alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 113
1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); 114
(12) Alpha-Methylthiofentanyl 115
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide116
); 117
(13) Benzethidine; 118
(14) Betacetylmethadol; 119
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 6 (MCL\KP)

(15) Beta-Hydroxyfentanyl 120
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); 121
(16) Beta-Hydroxy-3-methylfentanyl 122
(N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpr123
opanamide); 124
(17) Beta-Hydroxythiofentanyl 125
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpr126
opionamide); 127
(18) Betameprodine; 128
(19) Betamethadol; 129
(20) Beta-Methyl fentanyl 130
(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide), also 131
known as β-methyl fentanyl; 132
(21) Beta'-Phenyl fentanyl 133
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide), also 134
known as β'-phenyl fentanyl or 3-phenylpropanoyl fentanyl; 135
(22) Betaprodine; 136
(23) Brorphine (1–(1–(1–137
(4-bromophenyl)ethyl)piperidin-4–yl)–138
1,3-dihydro-2H-benzo[d]imidazol-2-one); 139
(24) Butyrl fentanyl 140
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); 141
(25) Clonitazene; 142
(26) Crotonyl fentanyl 143
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide); 144
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 7 (MCL\KP)

(27) Cyclopentyl fentanyl 145
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide); 146
(28) Cyclopropyl fentanyl 147
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); 148
(29) Dextromoramide; 149
(30) Diampromide; 150
(31) Diethylthiambutene; 151
(32) Difenoxin; 152
(33) Dimenoxadol; 153
(34) Dimepheptanol; 154
(35) 2′,5′-dimethoxyfentanyl 155
(N-1-2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide); 156
(36) Dimethylthiambutene; 157
(37) Dioxaphetyl butyrate; 158
(38) Dipipanone; 159
(39) Ethylmethylthiambutene; 160
(40) Etodesnitazene 161
(2-2-4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amin162
e, also known as etazene; 163
(41) Etonitazene; 164
(42) Etoxeridine; 165
(43) Fentanyl carbamate 166
(ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate); 167
(44) Fentanyl-related substances, meaning any substance 168
not otherwise listed under another schedule and for which no 169
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 8 (MCL\KP)

exemption or approval is in effect under Section 505 of the 170
Federal Food, Drug, and Cosmetic Act [21 USC 355] that is 171
structurally related to fentanyl by one or more of the following 172
modifications: 173
(A) Replacement of the phenyl portion of the 174
phenethyl group by any monocycle, whether or not further 175
substituted in or on the monocycle; 176
(B) Substitution in or on the phenethyl group with 177
alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro 178
groups; 179
(C) Substitution in or on the piperidine ring with 180
alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, 181
amino or nitro groups; 182
(D) Replacement of the aniline ring with any 183
aromatic monocycle whether or not further substituted in or on the 184
aromatic monocycle; and/or 185
(E) Replacement of the N-propionyl group by 186
another acyl group. 187
(45) 4-Fluoroisobutyryl fentanyl 188
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), 189
also known as para-fluoroisobutyryl fentanyl); 190
(46) 2'-Fluoro ortho-fluorofentanyl 191
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl) 192
propionamide), also known as 2'-fluoro 2-fluorofentanyl; 193
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 9 (MCL\KP)

(47) Furanyl fentanyl 194
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide); 195
(48) 3-furanyl fentanyl 196
(N-1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide); 197
(49) Furethidine; 198
(50) Hydroxypethidine; 199
(51) Isobutyryl fentanyl 200
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide); 201
(52) Isotonitazene (N,N-diethyl-2-(2-(4 202
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine); 203
(53) Isovaleryl fentanyl 204
(3-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 205
(54) Ketobemidone (including the optical and geometric 206
isomers); 207
(55) Levomoramide; 208
(56) Levophenacylmorphan; 209
(57) Meta-fluorofentanyl 210
(N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 211
(58) Meta-fluoroisobutyryl fentanyl 212
(N-(3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)isobutyramide); 213
(59) Methoxyacetyl fentanyl 214
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 215
(60) 4'-Methyl acetyl fentanyl 216
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); 217
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 10 (MCL\KP)

(61) 2-methyl AP–237 218
(1-2-methyl-4-3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one; 219
(62) 3-Methylfentanyl 220
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); 221
(63) 3-Methylthiofentanyl (N-[3-methyl-1- 222
(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide); 223
(64) Para-methoxyfuranyl fentanyl 224
(N-(4-methoxyphenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxami225
de); 226
(65) Metonitazene 227
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)e228
than-1-amine (metonitazene); 229
(66) Morpheridine; 230
(67) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 231
(68) MT-45 232
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); 233
(69) N-pyrrolidino etonitazene 234
2-4-ethoxybenzyl)-5-nitro-1-2-pyrrolidin-1-yl)ethyl)-1H-benzimidaz235
ole, also known as etonitazepyne; 236
(70) Noracymethadol; 237
(71) Norlevorphanol; 238
(72) Normethadone; 239
(73) Norpipanone; 240
(74) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N- 241
(1-phenethylpiperidin-4-yl)acetamide); 242
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 11 (MCL\KP)

(75) Ortho-Fluoroacryl fentanyl 243
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); 244
(76) Ortho-Fluorobutyryl fentanyl 245
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), also 246
known as 2-fluorobutyryl fentanyl; 247
(77) Ortho-Fluorofentanyl 248
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 249
also known as 2-fluorofentanyl; 250
(78) Ortho-fluorofuranyl fentanyl 251
(N-2-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide252
); 253
(79) Ortho-Fluoroisobutyryl fentanyl 254
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 255
(80) Ortho-Methyl acetylfentanyl 256
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide), also 257
known as 2-methyl acetylfentanyl; 258
(81) Ortho-Methyl methoxyacetyl fentanyl 259
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) 260
acetamide), also known as 2-methyl methoxyacetyl fentanyl; 261
(82) Para-Chloroisobutyryl fentanyl 262
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 263
(83) Para-Fluorobutyryl fentanyl 264
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 265
(84) Para-Fluorofentanyl (N-(4-fluorophenyl) 266
-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide); 267
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 12 (MCL\KP)

(85) Para-Fluoro furanyl fentanyl N-(4-fluorophenyl)-N- 268
(1-phenethylpiperidin-4-yl)furan-2-carboxamide); 269
(86) Para-Methoxybutyryl fentanyl 270
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 271
(87) Para-methylcyclopropyl fentanyl 272
(N-4-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxa273
mide); 274
(88) Para-Methylfentanyl 275
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 276
also known as 4-methylfentanyl); 277
(89) PEPAP 278
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 279
(90) Phenadoxone; 280
(91) Phenampromide; 281
(92) Phenomorphan; 282
(93) Phenoperidine; 283
(94) Phenyl fentanyl 284
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as 285
benzoyl fentanyl; 286
(95) Piritramide; 287
(96) Proheptazine; 288
(97) Properidine; 289
(98) Propiram; 290
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 13 (MCL\KP)

(99) Protonitazene 291
N,N-diethyl-2-5-nitro-2-4-propoxybenzyl)-1H-benzimidazol-1-yl)etha292
n-1-amine; 293
(100) Racemoramide; 294
(101) Tetrahydrofuranyl fentanyl 295
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- 296
carboxamide); 297
(102) Thiofentanyl 298
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide); 299
(103) Thiofuranyl fentanyl 300
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide), 301
also known as 2-thiofuranyl fentanyl or thiophene fentanyl; 302
(104) Tilidine; 303
(105) Trimeperidine; 304
(106) U-47700, (3,4-dichloro-N- 305
[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); 306
(107) Valeryl fentanyl 307
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide). 308
(c) Opium derivatives. Unless specifically excepted or 309
unless listed in another schedule, any of the following opium 310
derivatives, their salts, isomers and salts of isomers, whenever 311
the existence of these salts, isomers and salts of isomers is 312
possible within the specific chemical designation: 313
(1) Acetorphine; 314
(2) Acetyldihydrocodeine; 315
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 14 (MCL\KP)

(3) Benzylmorphine; 316
(4) Codeine methylbromide; 317
(5) Codeine-N-Oxide; 318
(6) Cyprenorphine; 319
(7) Desomorphine; 320
(8) Dihydromorphine; 321
(9) Drotebanol; 322
(10) Etorphine (except hydrochloride salt); 323
(11) Heroin; 324
(12) Hydromorphinol; 325
(13) Methyldesorphine; 326
(14) Methyldihydromorphine; 327
(15) Monoacetylmorphine; 328
(16) Morphine methylbromide; 329
(17) Morphine methylsulfonate; 330
(18) Morphine-N-Oxide; 331
(19) Myrophine; 332
(20) Nicocodeine; 333
(21) Nicomorphine; 334
(22) Normorphine; 335
(23) Pholcodine; 336
(24) Thebacon. 337
(d) Hallucinogenic substances. Unless specifically excepted 338
or unless listed in another schedule, any material, compound, 339
mixture or preparation which contains any quantity of the 340
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 15 (MCL\KP)

following substances, their salts, isomers (whether optical, 341
positional, or geometric) and salts of isomers, whenever the 342
existence of these salts, isomers and salts of isomers is possible 343
within the specific chemical designation: 344
(1) Alpha-ethyltryptamine; 345
(2) 4-bromo-2,5-dimethoxy-amphetamine; 346
(3) 4-bromo-2,5-dimethoxyphenethylamine; 347
(4) 2,5-dimethoxyamphetamine; 348
(5) 2,5-dimethoxy-4-ethylamphetamine (DOET); 349
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine 350
(2C-T-7); 351
(7) 4-methoxyamphetamine; 352
(8) 5-methoxy-3,4-methylenedioxy-amphetamine; 353
(9) 4-methyl-2,5-dimethoxy-amphetamine; 354
(10) 3,4-methylenedioxy amphetamine; 355
(11) 3,4-methylenedioxymethamphetamine (MDMA); 356
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known 357
as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl 358
MDA, MDE, MDEA); 359
(13) N-hydroxy-3,4-methylenedioxyamphetamine (also 360
known as N-hydroxy MDA, N-OHMDA, and 361
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine); 362
(14) 3,4,5-trimethoxy amphetamine; 363
(15) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT); 364
(16) Alpha-methyltryptamine (also known as AMT); 365
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 16 (MCL\KP)

(17) Bufotenine; 366
(18) Diethyltryptamine; 367
(19) Dimethyltryptamine; 368
(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT); 369
(21) Ibogaine; 370
(22) Lysergic acid diethylamide (LSD); 371
(23) (A) Marijuana (Hemp as defined and regulated 372
under Sections 69-25-201 through 69-25-221 and Cannabidiol 373
contained in a legend drug product approved by the Federal Food 374
and Drug Administration or obtained under Section 41-29-136 are 375
exempt under Schedule I); 376
(B) Hashish; 377
(24) Mescaline; 378
(25) Parahexyl; 379
(26) Peyote; 380
(27) N-ethyl-3-piperidyl benzilate; 381
(28) N-methyl-3-piperidyl benzilate; 382
(29) Psilocybin; 383
(30) Psilocyn; 384
(31) Tetrahydrocannabinols, meaning 385
tetrahydrocannabinols contained in a plant of the genus Cannabis 386
(cannabis plant), as well as the synthetic equivalents of the 387
substances contained in the cannabis plant, or in the resinous 388
extractives of such plant, and/or synthetic substances, 389
derivatives, and their isomers with similar chemical structure and 390
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 17 (MCL\KP)

pharmacological activity to those substances contained in the 391
plant such as the following: 392
(A) 1 cis or trans tetrahydrocannabinol; 393
(B) 6 cis or trans tetrahydrocannabinol; 394
(C) 3,4 cis or trans tetrahydrocannabinol. 395
(Since nomenclature of these substances is not 396
internationally standardized, compounds of these structures, 397
regardless of atomic positions, are covered.) 398
("Tetrahydrocannabinols" excludes dronabinol and nabilone.) 399
For purposes of this paragraph, tetrahydrocannabinols do not 400
include hemp or hemp products regulated under Sections 69-25-201 401
through 69-25-221. 402
However, the following products are exempted from control: 403
(i) THC-containing industrial products made 404
from cannabis stalks (e.g., paper, rope and clothing); 405
(ii) Processed cannabis plant materials used 406
for industrial purposes, such as fiber retted from cannabis stalks 407
for use in manufacturing textiles or rope; 408
(iii) Animal feed mixtures that contain 409
sterilized cannabis seeds and other ingredients (not derived from 410
the cannabis plant) in a formula designed, marketed and 411
distributed for nonhuman consumption; 412
(iv) Personal care products that contain oil 413
from sterilized cannabis seeds, such as shampoos, soaps, and body 414
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 18 (MCL\KP)

lotions (if the products do not cause THC to enter the human 415
body); 416
(v) Hemp as regulated under Sections 417
69-25-201 through 69-25-221; and 418
(vi) Any product derived from the hemp plant 419
designed for human ingestion and/or consumption that is approved 420
by the United States Food and Drug Administration; 421
(32) Phencyclidine; 422
(33) Ethylamine analog of phencyclidine (PCE); 423
(34) Pyrrolidine analog of phencyclidine (PHP, PCPy); 424
(35) Thiophene analog of phencyclidine; 425
(36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy); 426
(37) 4-methylmethcathinone (mephedrone); 427
(38) 3,4-methylenedioxypyrovalerone (MDPV); 428
(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E); 429
(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D); 430
(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 431
(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 432
or 2,5-dimethoxy-4-iodophenethylamine; 433
(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine 434
(2C-T-2); 435
(44) 436
2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 437
(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H); 438
(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N); 439
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 19 (MCL\KP)

(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine 440
(2C-P); 441
(48) 3,4-methylenedioxy-N-methylcathinone(methylone); 442
(49) 443
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 444
(25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36); 445
(50) 446
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 447
(25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82); 448
(51) 449
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 450
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; 451
Cimbi-5); 452
(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 453
4-benzodiazepin-2-one (also known as Phenazepam); 454
(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 455
11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene 456
(also known as Etizolam); 457
(54) Salvia divinorum; 458
(55) Synthetic cannabinoids. Unless specifically 459
excepted or unless listed in another schedule, any material, 460
compound, mixture, or preparation which contains any quantity of a 461
synthetic cannabinoid found in any of the following chemical 462
groups, whether or not substituted to any extent, or any of those 463
groups which contain any synthetic cannabinoid salts, isomers, or 464
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 20 (MCL\KP)

salts of isomers, whenever the existence of such salts, isomers, 465
or salts of isomers is possible within the specific chemical 466
designation, including all synthetic cannabinoid chemical 467
analogues in such groups: 468
(A) (6aR,10aR)-9-(hydroxymethyl)-6, 469
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] 470
chromen-1-ol (also known as HU-210 or 471
1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol); 472
(B) Naphthoylindoles and naphthylmethylindoles, 473
being any compound structurally derived from 3-(1-naphthoyl)indole 474
or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted 475
in the indole ring to any extent, or in the naphthyl ring to any 476
extent; 477
(C) Naphthoylpyrroles, being any compound 478
structurally derived from 3-(1-naphthoyl)pyrrole, whether or not 479
substituted in the pyrrole ring to any extent, or in the naphthyl 480
ring to any extent; 481
(D) Naphthylmethylindenes, being any compound 482
structurally derived from 1-(1-naphthylmethyl)indene, whether or 483
not substituted in the indene ring to any extent or in the 484
naphthyl ring to any extent; 485
(E) Phenylacetylindoles, being any compound 486
structurally derived from 3-phenylacetylindole, whether or not 487
substituted in the indole ring to any extent or in the phenyl ring 488
to any extent; 489
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 21 (MCL\KP)

(F) Cyclohexylphenols, being any compound 490
structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether 491
or not substituted in the cyclohexyl ring to any extent or in the 492
phenolic ring to any extent; 493
(G) Benzoylindoles, whether or not substituted in 494
the indole ring to any extent or in the phenyl ring to any extent; 495
(H) Adamantoylindoles, whether or not substituted 496
in the indole ring to any extent or in the adamantoyl ring system 497
to any extent; 498
(I) Tetrahydro derivatives of cannabinol and 499
3-alkyl homologues of cannabinol or of its tetrahydro derivatives, 500
except where contained in cannabis or cannabis resin; 501
(J) 3-Cyclopropylmethanone indole or 502
3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by 503
substitution at the nitrogen atom of the indole ring, whether or 504
not further substituted in the indole ring to any extent, whether 505
or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl 506
rings to any extent; 507
(K) Quinolinyl ester indoles, being any compound 508
structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl 509
ester, whether or not substituted in the indole ring to any extent 510
or the quinolone ring to any extent; 511
(L) 3-carboxamide-1H-indazoles, whether or not 512
substituted in the indazole ring to any extent and substituted to 513
any degree on the carboxamide nitrogen and 514
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 22 (MCL\KP)

3-carboxamide-1H-indoles, whether or not substituted in the indole 515
ring to any extent and substituted to any degree on the 516
carboxamide nitrogen; 517
(M) Cycloalkanemethanone Indoles, whether or not 518
substituted at the nitrogen atom on the indole ring, whether or 519
not further substituted in the indole ring to any extent, whether 520
or not substituted on the cycloalkane ring to any extent; 521
(56) Naphthalen-1-yl 522
1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 523
or CBL2201; 524
(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- 525
pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 526
5F-CUMYL-P7AICA or SGT-25; 527
(58) Methyl 528
2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutano529
ate, also known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA); 530
(59) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also 531
known as para-methoxymethamphetamine or PMMA; 532
(60) Ethyl 2-(1-(5-fluoropentyl) 533
-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, also known as 534
5F-EDMB-PINACA; 535
(61) Methyl 536
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoa537
te, also known as 5F-MDMB-PICA or 5F-MDMB-2201; 538
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 23 (MCL\KP)

(62) 539
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, 540
also known as FUB-AKB48 or FUB-APINACA or AKB48 541
N-(4-fluorobenzyl); 542
(63) 543
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)544
methanone, also known as FUB-144; 545
(64) N-ethylhexedrone, also known as 546
α-ethylaminohexanophenone or 2-(ethylamino)-1-phenylhexan-1-one; 547
(65) Alpha-pyrrolidinohexanophenone, also known as 548
α-PHP or α-pyrrolidinohexanophenone or 549
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one); 550
(66) 4-methyl-alpha-ethylaminopentiophenone, also known 551
as 4-MEAP or 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one); 552
(67) 4'-methyl-alpha-pyrrolidinohexiophenone, also 553
known as MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone or 554
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one); 555
(68) Alpha-pyrrolidinoheptaphenone (also known as PV8; 556
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one); 557
(69) 4'-chloro-alpha-pyrrolidinovalerophenone, also 558
known as 4-chloro-α-PVP or 4'-chloro-α-pyrrolidinopentiophenone or 559
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one); 560
(70) 561
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one, also known as 562
methoxetamine or MXE; 563
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 24 (MCL\KP)

(71) Zipeprol 564
(1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylp565
ropan-2-ol); 566
(72) Eutylone 567
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one); and 568
(73) ADB–BUTINACA 569
N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carb570
oxamide. 571
(e) Depressants. Unless specifically excepted or unless 572
listed in another schedule, any material, compound, mixture, or 573
preparation which contains any quantity of the following 574
substances having a depressant effect on the central nervous 575
system, including their salts, isomers, and salts of isomers, 576
whenever the existence of such salts, isomers, and salts of 577
isomers is possible within the specific chemical designation: 578
(1) Clonazolam, 579
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]580
benzodiazepine; 581
(2) Flualprazolam, 582
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4583
]benzodiazepine; 584
(3) Flubromazepam, 585
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 586
(4) Flubromazolam, 587
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 25 (MCL\KP)

8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]588
benzodiazepin; 589
(5) Gamma-hydroxybutyric acid (other names include: 590
GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic 591
acid; sodium oxybate; sodium oxybutyrate); 592
(6) Mecloqualone; 593
(7) Methaqualone. 594
(f) Stimulants. Any material, compound, mixture or 595
preparation which contains any quantity of the following central 596
nervous system stimulants including optical salts, isomers and 597
salts of isomers unless specifically excepted or unless listed in 598
another schedule: 599
(1) Aminorex; 600
(2) Amineptine 601
(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic 602
acid); 603
(3) N-benzylpiperazine (also known as BZP and 604
1-benzylpiperazine); 605
(4) Cathinone; 606
(5) 4,4'-Dimethylaminorex, also known as 4,4'-DMAR or 607
4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 608
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine); 609
(6) Fenethylline; 610
(7) Mesocarb 611
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 26 (MCL\KP)

(N-phenyl-N' -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3- 612
ium-5-yl)carbamimidate); 613
(8) Methcathinone; 614
(9) Methiopropamine 615
(N-methyl-1-(thiophen-2-yl)propan-2-amine)); 616
(10) 4-methylaminorex (also known as 617
2-amino-4-methyl-5-phenyl-2-oxazoline); 618
(11) N-ethylamphetamine; 619
(12) Any material, compound, mixture or preparation 620
which contains any quantity of N,N-dimethylamphetamine. (Other 621
names include: N,N,-alpha-trimethyl-benzeneethanamine and 622
N,N-alpha-trimethylphenethylamine); 623
(13) Synthetic cathinones. (A) Unless listed in 624
another schedule, any compound other than bupropion that is 625
structurally derived from 2-Amino-1-phenyl-1-propanone by 626
modification in any of the following ways: 627
(i) By substitution in the phenyl ring to any 628
extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide 629
substituents, whether or not further substituted in the phenyl 630
ring by one or more other univalent substituents; 631
(ii) By substitution at the 3-position with 632
an alkyl substituent; 633
(iii) By substitution at the nitrogen atom 634
with alkyl or dialkyl groups, or by inclusion of the nitrogen atom 635
in a cyclic structure. 636
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 27 (MCL\KP)

(B) The compounds covered in this paragraph (10) 637
include, but are not limited to, any material, compound, mixture 638
or preparation which contains any quantity of a synthetic 639
cathinone found in any of the following compounds, whether or not 640
substituted to any extent, or any of these compounds which contain 641
any synthetic cathinone, or salts, isomers, or salts of isomers, 642
whenever the existence of such salts, isomers or salts of isomers 643
is possible, unless specifically excepted or listed in another 644
schedule: 645
(i) 4-methyl-N-ethylcathinone ("4-MEC"); 646
(ii) 4-methyl-alpha-pyrrolidinopropiophenone 647
("4-MePPP"); 648
(iii) Alpha-pyrrolidinopentiophenone 649
("α-PVP"); 650
(iv) 1-(1,3-benzodioxol-5-yl)-2- 651
(methylamino)butan-1-one ("butylone"); 652
(v) 2-(methylamino)-1-phenylpentan-1-one 653
("pentedrone"); 654
(vi) 1-(1,3-benzodioxol-5-yl)-2- 655
(methylamino)pentan-1-one ("pentylone"); 656
(vii) 4-fluoro-N-methylcathinone ("4-FMC"); 657
(viii) 3-fluoro-N-methylcathinone ("3-FMC"); 658
(ix) 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl) 659
pentan-1-one ("naphyrone"); 660
(x) Alpha-pyrrolidinobutiophenone ("α-PBP"); 661
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 28 (MCL\KP)

(xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) 662
-pentan-1-one (N-ethylpentylone, ephylone); 663
(14) a-PiHP 664
4-methyl-1-phenyl-2-pyrrolidin-1-yl)pentan-1-one, also known as 665
alpha-PiHP; and 666
(15) 3–MMC 667
2-methylamino)-1-3-methylphenyl)propan-1-one, also known as 668
3-methylmethcathinone. 669
SECTION 3. Section 41-29-115, Mississippi Code of 1972, is 670
brought forward as follows: 671
41-29-115. (a) The controlled substances listed in this 672
section, by whatever official name, common or usual name, chemical 673
name, or brand name designated, are included in Schedule II. 674
SCHEDULE II 675
(b) Substances, vegetable origin or chemical synthesis. 676
Unless specifically excepted or unless listed in other schedules, 677
any of the following substances, whether produced directly or 678
indirectly by extraction from substances of vegetable origin, or 679
independently by means of chemical synthesis, or by combination of 680
extraction and chemical synthesis: 681
(1) Opium and opiate, and any salt, compound, 682
derivative, or preparation of opium or opiate, excluding 683
apomorphine, thebaine-derived butorphanol, dextrorphan, 684
nalbuphine, naldemedine, nalmefene, naloxegol, naloxone and 685
naltrexone, but including the following: 686
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 29 (MCL\KP)

(i) Codeine; 687
(ii) Dihydroetorphine; 688
(iii) Ethylmorphine; 689
(iv) Etorphine hydrochloride; 690
(v) Granulated opium; 691
(vi) Hydrocodone, whether alone or in combination 692
with any material, compound, mixture or preparation; 693
(vii) Hydromorphone; 694
(viii) Metopon; 695
(ix) Morphine; 696
(x) Opium extracts; 697
(xi) Opium fluid extracts; 698
(xii) Oripavine; 699
(xiii) Oxycodone; 700
(xiv) Oxymorphone; 701
(xv) Powdered opium; 702
(xvi) Raw opium; 703
(xvii) Thebaine; 704
(xviii) Tincture of opium; 705
(2) Any salt, compound, isomer, derivative, or 706
preparation thereof which is chemically equivalent or identical 707
with any of the substances referred to in paragraph (1), but not 708
including the isoquinoline alkaloids of opium; 709
(3) Opium poppy and poppy straw; 710
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 30 (MCL\KP)

(4) Coca leaves and any salt, compound, derivative, or 711
preparation of cocaine or coca leaves, including cocaine and 712
ecgonine and any salt, compound, derivative, isomer, or 713
preparation thereof which is chemically equivalent or identical 714
with any of these substances, but not including: 715
(i) Decocainized coca leaves or extraction of coca 716
leaves, which extractions do not contain cocaine or ecgonine; or 717
(ii) Ioflupane; 718
(5) Concentrate of poppy straw (the crude extract of 719
poppy straw in either liquid, solid or powder form which contains 720
the phenanthrene alkaloids of the opium poppy). 721
(c) Opiates. Any of the following opiates, including their 722
isomers, esters, ethers, salts, and salts of isomers, whenever the 723
existence of these isomers, esters, ethers and salts is possible 724
within the specified chemical designation, dextrorphan and 725
levopropoxyphene excepted: 726
(1) Alfentanil; 727
(2) Alphaprodine; 728
(3) Anileridine; 729
(4) Bezitramide; 730
(5) Bulk dextropropoxyphene (nondosage forms); 731
(6) Carfentanil; 732
(7) Dihydrocodeine; 733
(8) Diphenoxylate; 734
(9) Fentanyl; 735
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 31 (MCL\KP)

(10) Isomethadone; 736
(11) Levo-alphacetylmethadol 737
(levo-alpha-acetylmethadol, levomethadyl acetate, LAAM); 738
(12) Levomethorphan; 739
(13) Levorphanol; 740
(14) Metazocine; 741
(15) Methadone; 742
(16) Methadone-intermediate, 743
4-cyano-2-dimethylamino-4,4-diphenyl butane; 744
(17) Moramide-intermediate, 745
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid; 746
(18) Oliceridine 747
(N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6- 748
oxaspiro[4.5]decan-9-yl]ethyl})amine); 749
(19) Pethidine (meperidine); 750
(20) Pethidine-Intermediate-A, 751
4-cyano-1-methyl-4-phenylpiperidine; 752
(21) Pethidine-Intermediate-B, 753
ethyl-4-phenylpiperidine-4-carboxylate; 754
(22) Pethidine-Intermediate-C, 755
1-methyl-4-phenylpiperidine-4-carboxylic acid; 756
(23) Phenazocine; 757
(24) Piminodine; 758
(25) Racemethorphan; 759
(26) Racemorphan; 760
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 32 (MCL\KP)

(27) Remifentanil; 761
(28) Sufentanil; 762
(29) Tapentadol; 763
(30) Thiafentanil, methyl 764
4-(2-methoxy-N-phenylacetamido)-1-(2-(thiophen-2-yl)ethyl) 765
piperidine-4-carboxylate). 766
(d) Stimulants. Any material, compound, mixture, or 767
preparation which contains any quantity of the following 768
substances: 769
(1) Amphetamine, its salts, optical isomers, and salts 770
of its optical isomers; 771
(2) Phenmetrazine and its salts; 772
(3) Any substance which contains any quantity of 773
methamphetamine, including its salts, isomers, and salts of 774
isomers; 775
(4) Methylphenidate and its salts; 776
(5) Lisdexamfetamine, its salts, isomers and salts of 777
isomers. 778
(e) Depressants. Unless specifically exempted or unless 779
listed in another schedule, any material, compound, mixture, or 780
preparation which contains any quantity of the following 781
substances: 782
(1) Amobarbital; 783
(2) Secobarbital; 784
(3) Pentobarbital; 785
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 33 (MCL\KP)

(4) Glutethimide. 786
(f) Hallucinogenic substances. 787
(1) Dronabinol oral solution 788
[(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)]; 789
(2) Nabilone [other names include: 790
(+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- 791
hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo(b,d)pyran-9-one]. 792
(g) Immediate precursors. Unless specifically excepted or 793
unless listed in another schedule, any material, compound, 794
mixture, or preparation which contains any quantity of the 795
following substances: 796
(1) Amphetamine and methamphetamine immediate 797
precursor: Phenylacetone (other names include: 798
phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl 799
ketone); 800
(2) Phencyclidine immediate precursors: 801
(i) 1-phenylcyclohexylamine; 802
(ii) 1-piperidinocyclohexanecarbonitrile (PCC); 803
(3) Fentanyl immediate precursor: 804
4-anilino-N-phenethyl-4-piperidine (ANPP). 805
(h) Any material, compound, mixture or preparation which 806
contains any quantity of a Schedule II controlled substance and is 807
listed as an exempt substance in 21 CFR, Section 1308.24 or 808
1308.32, shall be exempted from the provisions of the Uniform 809
Controlled Substances Law. 810
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 34 (MCL\KP)

SECTION 4. Section 41-29-117, Mississippi Code of 1972, is 811
brought forward as follows: 812
41-29-117. (A) The controlled substances listed in this 813
section are included in Schedule III. 814
SCHEDULE III 815
(a) Stimulants. Any material, compound, mixture, or 816
preparation which contains any quantity of the following 817
substances or their salts, isomers, or salts of isomers, of the 818
following substances: 819
(1) Benzphetamine; 820
(2) Chlorphentermine; 821
(3) Clortermine; 822
(4) Phendimetrazine. 823
(b) Depressants. Unless listed in another schedule, 824
any material, compound, mixture, or preparation which contains any 825
quantity of the following substances: 826
(1) Any substance which contains any quantity of a 827
derivative of barbituric acid, or any salt of a derivative of 828
barbituric acid, except those substances which are specifically 829
listed in other schedules; 830
(2) Unless specifically excepted or unless listed 831
in another schedule, any compound, mixture or preparation 832
containing any of the following substances or any salt of the 833
substances specifically included in this subsection (2) and one or 834
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 35 (MCL\KP)

more other active medicinal ingredients which are not listed in 835
any other schedule: 836
(i) Amobarbital; 837
(ii) Secobarbital; 838
(iii) Pentobarbital; 839
(3) Any suppository dosage form containing any of 840
the following substances or any salt of any of the substances 841
specifically included in this subsection (3) approved by the Food 842
and Drug Administration for marketing only as a suppository: 843
(i) Amobarbital; 844
(ii) Secobarbital; 845
(iii) Pentobarbital; 846
(4) Chlorhexadol; 847
(5) Embutramide; 848
(6) Any drug product containing 849
gamma-hydroxybutyric acid, including its salts, isomers and salts 850
of isomers, for which an application is approved under Section 505 851
of the Federal Food, Drug and Cosmetic Act; 852
(7) Ketamine; its salts, isomers, and salts of 853
isomers; other names include 854
(+)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone; 855
(8) Lysergic acid; 856
(9) Lysergic acid amide; 857
(10) Methyprylon; 858
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 36 (MCL\KP)

(11) Perampanel; its salts, isomers, and salts of 859
isomers; 860
(12) Sulfondiethylmethane; 861
(13) Sulfonethylmethane; 862
(14) Sulfonmethane; 863
(15) Tiletamine and zolazepam or any salt thereof; 864
other names for the tiletamine and zolazepam combination product 865
include: telazol; other names for tiletamine include: 866
2-(ethylamino)-2-(2-thienyl)-cyclohexanone; other names for 867
zolazepam include: 4-(2-fluorophenyl)-6,8-dihydro 1,3, 868
8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon. 869
(c) Nalorphine. 870
(d) Any material, compound, mixture or preparation 871
which contains any quantity of ephedrine or pseudoephedrine, 872
except for any product that contains any quantity of 873
pseudoephedrine or ephedrine that is sold subject to the quantity 874
restrictions authorized in Section 73-21-124. 875
(e) Narcotic drugs. Any material, compound, mixture, 876
or preparation containing limited quantities of any of the 877
following narcotic drugs, or any salts thereof: 878
(1) Not more than one and eight-tenths (1.8) grams 879
of codeine, or any of its salts, per one hundred (100) milliliters 880
or not more than ninety (90) milligrams per dosage unit, with an 881
equal or greater quantity of an isoquinoline alkaloid of opium; 882
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 37 (MCL\KP)

(2) Not more than one and eight-tenths (1.8) grams 883
of codeine, or any of its salts, per one hundred (100) milliliters 884
or not more than ninety (90) milligrams per dosage unit, with one 885
or more active, nonnarcotic ingredients in recognized therapeutic 886
amounts; 887
(3) Not more than one and eight-tenths (1.8) grams 888
of dihydrocodeine, or any of its salts, per one hundred (100) 889
milliliters or not more than ninety (90) milligrams per dosage 890
unit, with one or more active, nonnarcotic ingredients in 891
recognized therapeutic amounts; 892
(4) Not more than three hundred (300) milligrams 893
of ethylmorphine, or any of its salts, per one hundred (100) 894
milliliters or not more than fifteen (15) milligrams per dosage 895
unit, with one or more active, nonnarcotic ingredients in 896
recognized therapeutic amounts; 897
(5) Not more than five hundred (500) milligrams of 898
opium per one hundred (100) milliliters or per one hundred (100) 899
grams, or not more than twenty-five (25) milligrams per dosage 900
unit, with one or more active, nonnarcotic ingredients in 901
recognized therapeutic amounts; 902
(6) Not more than fifty (50) milligrams of 903
morphine, or any of its salts, per one hundred (100) milliliters 904
or per one hundred (100) grams with one or more active, 905
nonnarcotic ingredients in recognized therapeutic amounts. 906
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 38 (MCL\KP)

(f) Anabolic steroids. Unless specifically exempted or 907
listed in another schedule, any material, compound, mixture or 908
preparation containing any quantity of any of the following 909
anabolic steroids (any drug or hormonal substance chemically and 910
pharmacologically related to testosterone other than estrogens, 911
progestins, corticosteroids and dehydroepiandrosterone): 912
(1) 3beta,17-dihydroxy-5a-androstane; 913
(2) 3alpha,17beta-dihydroxy-5a-androstane; 914
(3) 5alpha-androstan-3,17-dione; 915
(4) 1-androstenediol 916
(3beta,17beta-dihydroxy-5alpha-androst-1-ene); 917
(5) 1-androstenediol 918
(3alpha,17beta-dihydroxy-5alpha-androst-1-ene); 919
(6) 4-androstenediol 920
(3beta,17beta-dihydroxy-androst-4-ene); 921
(7) 5-androstenediol 922
(3beta,17beta-dihydroxy-androst-5-ene); 923
(8) 1-androstenedione ([5alpha]-androst-1-en-3, 924
17-dione); 925
(9) 4-androstenedione (androst-4-en-3,17-dione); 926
(10) 5-androstenedione (androst-5-en-3,17-dione); 927
(11) Bolasterone 928
(7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); 929
(12) Boldenone 930
(17beta-hydroxyandrost-1,4,-diene-3-one); 931
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 39 (MCL\KP)

(13) Boldione (androsta-1,4-diene-3,17-dione); 932
(14) Calusterone 933
(7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); 934
(15) Clostebol 935
(4-chloro-17beta-hydroxyandrost-4-en-3-one); 936
(16) Dehydrochloromethyltestosterone 937
(4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one); 938
(17) Desoxymethyltestosterone 939
(17alpha-methyl-5alpha-androst-2-en-17beta-ol, also known as 940
madol); 941
(18) Delta1-dihydrotestosterone (also known as 942
1-testosterone) (17beta-hydroxy-5alpha-androst-1-en-3-one); 943
(19) 4-dihydrotestosterone 944
(17beta-hydroxy-androstan-3-one); 945
(20) Drostanolone 946
(17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one); 947
(21) Ethylestrenol 948
(17alpha-ethyl-17beta-hydroxyestr-4-ene); 949
(22) Fluoxymesterone 950
(9-fluoro-17alpha-methyl-11beta, 951
17beta-dihydroxyandrost-4-en-3-one); 952
(23) Formebolone 953
(2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, 954
4-dien-3-one); 955
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 40 (MCL\KP)

(24) Furazabol 956
(17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan); 957
(25) 13beta-ethyl-17alpha-hydroxygon-4-en-3-one; 958
(26) 4-hydroxytestosterone 959
(4,17beta-dihydroxyandrost-4-en-3-one); 960
(27) 4-hydroxy-19-nortestosterone 961
(4,17beta-dihydroxy-estr-4-en-3-one); 962
(28) Mestanolone 963
(17alpha-methyl-17beta-hydroxy-5-androstan-3-one); 964
(29) Mesterolone 965
(1alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one); 966
(30) Methandienone 967
(17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one); 968
(31) Methandriol (17alpha-methyl-3beta, 969
17beta-dihydroxyandrost-5-ene); 970
(32) Methasterone (2[alpha], 971
17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one; 972
(33) Methenolone 973
(1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one); 974
(34) 17alpha-methyl-3beta, 975
17beta-dihydroxy-5a-androstane; 976
(35) 17alpha-methyl-3alpha, 977
17beta-dihydroxy-5a-androstane; 978
(36) 17alpha-methyl-3beta, 979
17beta-dihydroxyandrost-4-ene; 980
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 41 (MCL\KP)

(37) 17alpha-methyl-4-hydroxynandrolone 981
(17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); 982
(38) Methyldienolone 983
(17alpha-methyl-17beta-hydroxyestra-4,9(10)-dien-3-one); 984
(39) Methyltrienolone 985
(17alpha-methyl-17beta-hydroxyestra-4,9-11-trien-3-one); 986
(40) Methyltestosterone 987
(17alpha-methyl-17beta-hydroxyandrost-4-en-3-one); 988
(41) Mibolerone 989
(7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one); 990
(42) 17alpha-methyl-Delta1-dihydrotestosterone (17b 991
beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known 992
as 17-alpha-methyl-1-testosterone); 993
(43) Nandrolone (17beta-hydroxyestr-4-en-3-one); 994
(44) 19-nor-4-androstenediol 995
(3beta,17beta-dihydroxyestr-4-ene); 996
(45) 19-nor-4-androstenediol 997
(3a,17beta-dihydroxyestr-4-ene); 998
(46) 19-nor-5-androstenediol 999
(3beta,17beta-dihydroxyestr-5-ene); 1000
(47) 19-nor-5-androstenediol 1001
(3alpha,17beta-dihydroxyestr-5-ene); 1002
(48) 19-nor-4,9(10)-androstadienedione 1003
(estra-4,9(10)-diene3,17-dione, 1004
19-norandrosta-4,9(10)-diene-3,17-dione); 1005
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 42 (MCL\KP)

(49) 19-nor-4-androstenedione 1006
(estr-4-en-3,17-dione); 1007
(50) 19-nor-5-androstenedione 1008
(estr-5-en-3,17-dione); 1009
(51) Norbolethone 1010
(13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one); 1011
(52) Norclostebol 1012
(4-chloro-17beta-hydroxyestr-4-en-3-one); 1013
(53) Norethandrolone 1014
(17alpha-ethyl-17beta-hydroxyestr-4-en-3-one); 1015
(54) Normethandrolone 1016
(17alpha-methyl-17beta-hydroxyestr-4-en-3-one); 1017
(55) Oxandrolone 1018
(17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one); 1019
(56) Oxymesterone 1020
(17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one); 1021
(57) Oxymetholone 1022
(17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- 1023
androstan-3-one); 1024
(58) Prostanozol 1025
(17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) 1026
(59) Stanozolol 1027
(17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- 1028
pyrazole); 1029
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 43 (MCL\KP)

(60) Stenbolone 1030
(17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one); 1031
(61) Testolactone 1032
(13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid 1033
lactone); 1034
(62) Testosterone 1035
(17beta-hydroxyandrost-4-en-3-one); 1036
(63) Tetrahydrogestrinone 1037
(13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one); 1038
(64) Trenbolone 1039
(17beta-hydroxyestr-4,9,11-trien-3-one); 1040
(65) Any salt, ester, or ether of a drug or 1041
substance described in this paragraph. Except such term does not 1042
include an anabolic steroid that is expressly intended for 1043
administration through implants to cattle or other nonhuman 1044
species and that has been approved by the Secretary of Health and 1045
Human Services for such administration. If any person prescribes, 1046
dispenses, or distributes such steroid for human use, the person 1047
shall be considered to have prescribed, dispensed or distributed 1048
an anabolic steroid within the meaning of this paragraph. 1049
(g) Any material, compound, mixture or preparation 1050
which contains any quantity of buprenorphine or its salts. 1051
(h) Dronabinol (synthetic) in sesame oil and 1052
encapsulated in a soft gelatin capsule in a United States Food and 1053
Drug Administration approved drug product. 1054
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 44 (MCL\KP)

(i) Any material, compound, mixture, or preparation 1055
which contains any quantity of Tianeptine 1056
(7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]th1057
iazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts 1058
of isomers, sulfate, free acid or derivative thereof. 1059
(B) Any material, compound, mixture or preparation which 1060
contains any quantity of a Schedule III controlled substance other 1061
than butalbital, and is listed as an exempt substance in 21 CFR, 1062
Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be 1063
exempted from the provisions of the Uniform Controlled Substances 1064
Law. 1065
SECTION 5. Section 41-29-119, Mississippi Code of 1972, is 1066
brought forward as follows: 1067
41-29-119. (A) The controlled substances listed in this 1068
section are included in Schedule IV. 1069
SCHEDULE IV 1070
(a) Narcotic drugs. Unless specifically excepted or 1071
unless listed in another schedule, any material, compound, mixture 1072
or preparation which contains limited quantities of the following 1073
narcotic drugs, or any salts thereof: 1074
(1) Not more than one (1) milligram of difenoxin 1075
and not less than twenty-five (25) micrograms of atropine sulfate 1076
per dosage unit; 1077
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 45 (MCL\KP)

(2) Dextropropoxyphene, including its salts 1078
(Darvon, Darvon-N; also found in Darvon compound and Darvocet-N, 1079
etc.); 1080
(3) 1081
2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its 1082
salts, optical and geometric isomers and salts of these isomers 1083
(including tramadol). 1084
(b) Depressants. Any material, compound, mixture or 1085
preparation which contains any quantity of the following 1086
substances: 1087
(1) Alfaxalone; 1088
(2) Alprazolam; 1089
(3) Barbital; 1090
(4) Brexanolone; 1091
(5) Bromazepam; 1092
(6) Camazepam; 1093
(7) Carisoprodol; 1094
(8) Chloral betaine; 1095
(9) Chloral hydrate; 1096
(10) Chlordiazepoxide and its salts, but does not 1097
include chlordiazepoxide hydrochloride and clidinium bromide or 1098
chlordiazepoxide and esterified estrogens; 1099
(11) Clobazam; 1100
(12) Clonazepam; 1101
(13) Clorazepate; 1102
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 46 (MCL\KP)

(14) Clotiazepam; 1103
(15) Cloxazolam; 1104
(16) Daridorexant 1105
([(S)-2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2- 1106
methylpyrrolidin-1-yl](5-methoxy-2-(2H-1,2,3-triazol-2- 1107
yl)phenyl)methanone), including its salts, isomers, and salts of 1108
isomers; 1109
(17) Delorazepam; 1110
(18) Diazepam; 1111
(19) Dichloralphenazone; 1112
(20) Estazolam; 1113
(21) Ethchlorvynol; 1114
(22) Ethinamate; 1115
(23) Ethyl loflazepate; 1116
(24) Fludiazepam; 1117
(25) Flunitrazepam; 1118
(26) Flurazepam; 1119
(27) Fospropofol; 1120
(28) Halazepam; 1121
(29) Haloxazolam; 1122
(30) Ketazolam; 1123
(31) Lemborexant; 1124
(32) Loprazolam; 1125
(33) Lorazepam; 1126
(34) Lormetazepam; 1127
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 47 (MCL\KP)

(35) Mebutamate; 1128
(36) Medazepam; 1129
(37) Meprobamate; 1130
(38) Methohexital; 1131
(39) Methylphenobarbital; 1132
(40) Midazolam; 1133
(41) Nimetazepam; 1134
(42) Nitrazepam; 1135
(43) Nordiazepam; 1136
(44) Oxazepam; 1137
(45) Oxazolam; 1138
(46) Paraldehyde; 1139
(47) Petrichloral; 1140
(48) Phenobarbital; 1141
(49) Pinazepam; 1142
(50) Prazepam; 1143
(51) Quazepam; 1144
(52) Remimazolam; 1145
(53) Suvorexant; 1146
(54) Temazepam; 1147
(55) Tetrazepam; 1148
(56) Triazolam; 1149
(57) Zaleplon; 1150
(58) Zolpidem; 1151
(59) Zopiclone. 1152
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 48 (MCL\KP)

(c) [Deleted] 1153
(d) Lorcaserin. Any material, compound, mixture, or 1154
preparation which contains any quantity of Lorcaserin, including 1155
its salts, isomers, and salts of such isomers, whenever the 1156
existence of such salts, isomers, and salts of isomers is 1157
possible. 1158
(e) Stimulants. Any material, compound, mixture or 1159
preparation which contains any quantity of the following 1160
substances: 1161
(1) Cathine ((+/-) Norpseudoephedrine); 1162
(2) Diethylpropion; 1163
(3) Fencamfamin; 1164
(4) Fenproporex; 1165
(5) Mazindol; 1166
(6) Mefenorex; 1167
(7) Modafinil; 1168
(8) Pemoline (including any organometallic 1169
complexes and chelates thereof); 1170
(9) Phentermine; 1171
(10) Pipradrol; 1172
(11) Serdexmethylphenidate; 1173
(12) Sibutramine; 1174
(13) Solriamfetol; 1175
(14) SPA ((-)-1-dimethylamino-1,2-diphenylethane). 1176
(f) Other substances. 1177
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 49 (MCL\KP)

(1) Pentazocine; 1178
(2) Butorphanol (including its optical isomers); 1179
(3) Eluxadoline 1180
(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopr1181
opyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-meth1182
oxybenzoic acid); (including its optical isomers) and its salts, 1183
isomers, and salts of isomers; 1184
(4) Zuranolone and its salts, isomers, and salts 1185
of isomers. 1186
(B) Any material, compound, mixture or preparation which 1187
contains any quantity of a Schedule IV controlled substance and is 1188
listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1189
1308.26, 1308.32 or 1308.34, shall be exempted from the provisions 1190
of the Uniform Controlled Substances Law. 1191
SECTION 6. Section 41-29-121, Mississippi Code of 1972, is 1192
brought forward as follows: 1193
41-29-121. 1194
SCHEDULE V 1195
(a) Schedule V consists of the drugs and other substances, 1196
by whatever official name, common or usual name, chemical name, or 1197
brand name designated, listed in this section. 1198
(b) Narcotic drugs. [Reserved] 1199
(c) Narcotic drugs containing nonnarcotic active medicinal 1200
ingredients. Any compound, mixture or preparation containing any 1201
of the following narcotic drugs, or their salts calculated as the 1202
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 50 (MCL\KP)

free anhydrous base or alkaloid, in limited quantities as set 1203
forth below, which also contains one or more nonnarcotic active 1204
medicinal ingredients in sufficient proportion to confer upon the 1205
compound, mixture or preparation valuable medicinal qualities 1206
other than those possessed by the narcotic drug alone: 1207
(1) Not more than two hundred (200) milligrams of 1208
codeine, or any of its salts, per one hundred (100) milliliters or 1209
per one hundred (100) grams; 1210
(2) Not more than one hundred (100) milligrams of 1211
dihydrocodeine, or any of its salts, per one hundred (100) 1212
milliliters or per one hundred (100) grams; 1213
(3) Not more than one hundred (100) milligrams of 1214
ethylmorphine, or any of its salts, per one hundred (100) 1215
milliliters or per one hundred (100) grams; 1216
(4) Not more than two and five-tenths (2.5) milligrams 1217
of diphenoxylate and not less than twenty-five (25) micrograms of 1218
atropine sulphate per dosage unit; 1219
(5) Not more than one hundred (100) milligrams of opium 1220
per one hundred (100) milliliters or per one hundred (100) grams; 1221
(6) Not more than five-tenths (0.5) milligram of 1222
difenoxin and not less than twenty-five (25) micrograms of 1223
atropine sulfate per dosage unit. 1224
(d) Stimulants. Unless specifically excepted or listed in 1225
another schedule, any material, compound, mixture or preparation 1226
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 51 (MCL\KP)

which contains any quantity of the following substance, including 1227
its salts, isomers and salts of isomers: Pyrovalerone. 1228
(e) Depressants. Unless specifically exempted or excluded 1229
or unless listed in another schedule, any material, compound, 1230
mixture or preparation which contains any quantity of the 1231
following substances having a depressant effect on the central 1232
nervous system, including their salts, isomers and salts of 1233
isomers: 1234
(1) Brivaracetam 1235
((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also 1236
referred to as BRV; UCB-34714; Briviact); 1237
(2) Cenobamate 1238
([(1R)-1-2-chlorophenyl)-2-tetrazol-2-yl)ethyl] carbamate; 1239
2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate 1240
(ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl) 1241
-2-(2H-tetrazol-2-yl)ethyl ester); 1242
(3) Ezogabine [N-[2-amino-4-(4- 1243
fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]; 1244
(4) Ganaxolone 1245
(3a-hydroxy-3b-methyl-5a-pregnan-20-one); 1246
(5) Lacosamide 1247
[(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]; 1248
(6) Lasmiditan [2,4,6-trifluoro-N-(6- 1249
(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]; 1250
H. B. No. 563 *HR43/R1104* ~ OFFICIAL ~
26/HR43/R1104
PAGE 52 (MCL\KP)
ST: Controlled substances; provide for
automatic scheduling of psilocybin after federal
scheduling.
(7) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic 1251
acid]. 1252
(f) Any material, compound, mixture or preparation which 1253
contains any quantity of a Schedule V controlled substance and is 1254
listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1255
1308.26, 1308.32 or 1308.34, shall be exempted from the provisions 1256
of the Uniform Controlled Substances Law. 1257
SECTION 7. This act shall take effect and be in force from 1258
and after its passage. 1259